Annual Total Assets
$144.40 M
-$51.02 M-26.11%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual total assets is $144.40 million, with the most recent change of -$51.02 million (-26.11%) on December 31, 2023.
- During the last 3 years, ABUS annual total assets has risen by +$7.32 million (+5.34%).
- ABUS annual total assets is now -79.73% below its all-time high of $712.29 million, reached on December 31, 2015.
Performance
ABUS Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$140.44 M
-$19.60 M-12.25%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly total assets is $140.44 million, with the most recent change of -$19.60 million (-12.25%) on September 30, 2024.
- Over the past year, ABUS quarterly total assets has dropped by -$9.85 million (-6.55%).
- ABUS quarterly total assets is now -82.16% below its all-time high of $787.06 million, reached on March 31, 2015.
Performance
ABUS Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ABUS Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -26.1% | -6.5% |
3 y3 years | +5.3% | -28.1% |
5 y5 years | -36.6% | -28.1% |
ABUS Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -29.4% | at low | -40.7% | at low |
5 y | 5-year | -29.4% | +36.8% | -40.7% | +43.9% |
alltime | all time | -79.7% | +2292.9% | -82.2% | +1264.5% |
Arbutus Biopharma Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $140.44 M(-12.2%) |
Jun 2024 | - | $160.04 M(+6.5%) |
Mar 2024 | - | $150.29 M(+4.1%) |
Dec 2023 | $144.40 M(-26.1%) | $144.40 M(-9.0%) |
Sep 2023 | - | $158.64 M(-10.3%) |
Jun 2023 | - | $176.82 M(-7.5%) |
Mar 2023 | - | $191.22 M(-2.1%) |
Dec 2022 | $195.42 M(-4.4%) | $195.42 M(-4.1%) |
Sep 2022 | - | $203.80 M(-5.6%) |
Jun 2022 | - | $215.84 M(-8.9%) |
Mar 2022 | - | $236.88 M(+15.8%) |
Dec 2021 | $204.49 M(+49.2%) | $204.49 M(+23.5%) |
Sep 2021 | - | $165.60 M(+22.3%) |
Jun 2021 | - | $135.38 M(-7.4%) |
Mar 2021 | - | $146.24 M(+6.7%) |
Dec 2020 | $137.08 M(+29.9%) | $137.08 M(+4.6%) |
Sep 2020 | - | $131.10 M(+34.3%) |
Jun 2020 | - | $97.63 M(-4.9%) |
Mar 2020 | - | $102.61 M(-2.8%) |
Dec 2019 | $105.53 M(-53.7%) | $105.53 M(-10.0%) |
Sep 2019 | - | $117.28 M(-39.1%) |
Jun 2019 | - | $192.57 M(-8.0%) |
Mar 2019 | - | $209.22 M(-8.2%) |
Dec 2018 | $227.91 M(-3.9%) | $227.91 M(-7.1%) |
Sep 2018 | - | $245.42 M(-11.4%) |
Jun 2018 | - | $277.01 M(+2.6%) |
Mar 2018 | - | $270.03 M(+13.9%) |
Dec 2017 | $237.16 M(-14.0%) | $237.16 M(-1.1%) |
Sep 2017 | - | $239.84 M(-6.0%) |
Jun 2017 | - | $255.07 M(-4.9%) |
Mar 2017 | - | $268.14 M(-2.8%) |
Dec 2016 | $275.92 M(-61.3%) | $275.92 M(-46.4%) |
Sep 2016 | - | $514.73 M(-3.0%) |
Jun 2016 | - | $530.86 M(-24.5%) |
Mar 2016 | - | $703.25 M(-1.3%) |
Dec 2015 | $712.29 M(+502.7%) | $712.29 M(-1.4%) |
Sep 2015 | - | $722.63 M(-6.6%) |
Jun 2015 | - | $773.82 M(-1.7%) |
Mar 2015 | - | $787.06 M(+566.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | $118.18 M(+64.8%) | $118.18 M(-5.5%) |
Sep 2014 | - | $125.06 M(-5.3%) |
Jun 2014 | - | $132.07 M(-4.7%) |
Mar 2014 | - | $138.52 M(+93.2%) |
Dec 2013 | $71.72 M(+36.4%) | $71.72 M(+65.3%) |
Sep 2013 | - | $43.38 M(-5.5%) |
Jun 2013 | - | $45.91 M(-9.1%) |
Mar 2013 | - | $50.50 M(-4.0%) |
Dec 2012 | $52.60 M(+283.8%) | $52.60 M(+411.0%) |
Sep 2012 | - | $10.29 M(-11.5%) |
Jun 2012 | - | $11.63 M(-20.8%) |
Mar 2012 | - | $14.69 M(+7.2%) |
Dec 2011 | $13.70 M(-34.8%) | $13.70 M(-7.8%) |
Sep 2011 | - | $14.86 M(-22.0%) |
Jun 2011 | - | $19.05 M(+9.5%) |
Mar 2011 | - | $17.41 M(-17.2%) |
Dec 2010 | $21.02 M(-24.8%) | $21.02 M(-40.3%) |
Sep 2010 | - | $35.22 M(-0.4%) |
Jun 2010 | - | $35.36 M(-4.5%) |
Mar 2010 | - | $37.05 M(+32.5%) |
Dec 2009 | $27.96 M(-34.0%) | $27.96 M(-35.6%) |
Sep 2009 | - | $43.45 M(+4.3%) |
Jun 2009 | - | $41.65 M(+4.9%) |
Mar 2009 | - | $39.71 M(-6.2%) |
Dec 2008 | $42.34 M(+70.5%) | $42.34 M(-18.8%) |
Sep 2008 | - | $52.15 M(-16.1%) |
Jun 2008 | - | $62.19 M(+180.0%) |
Mar 2008 | - | $22.21 M(-10.6%) |
Dec 2007 | $24.83 M(+311.5%) | $24.83 M(-4.0%) |
Sep 2007 | - | $25.87 M(+3.7%) |
Jun 2007 | - | $24.96 M |
Dec 2006 | $6.03 M(-67.4%) | - |
Dec 2005 | $18.50 M(-55.0%) | - |
Dec 2004 | $41.10 M(-19.0%) | - |
Dec 2003 | $50.73 M(-4.7%) | - |
Dec 2002 | $53.23 M(-21.3%) | - |
Dec 2001 | $67.60 M(+107.9%) | - |
Dec 2000 | $32.52 M(+12.9%) | - |
Dec 1999 | $28.80 M(+81.9%) | - |
Dec 1998 | $15.83 M | - |
FAQ
- What is Arbutus Biopharma annual total assets?
- What is the all time high annual total assets for Arbutus Biopharma?
- What is Arbutus Biopharma annual total assets year-on-year change?
- What is Arbutus Biopharma quarterly total assets?
- What is the all time high quarterly total assets for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly total assets year-on-year change?
What is Arbutus Biopharma annual total assets?
The current annual total assets of ABUS is $144.40 M
What is the all time high annual total assets for Arbutus Biopharma?
Arbutus Biopharma all-time high annual total assets is $712.29 M
What is Arbutus Biopharma annual total assets year-on-year change?
Over the past year, ABUS annual total assets has changed by -$51.02 M (-26.11%)
What is Arbutus Biopharma quarterly total assets?
The current quarterly total assets of ABUS is $140.44 M
What is the all time high quarterly total assets for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly total assets is $787.06 M
What is Arbutus Biopharma quarterly total assets year-on-year change?
Over the past year, ABUS quarterly total assets has changed by -$9.85 M (-6.55%)